Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
Dysglycaemic disease is one of the most important health issues facing the world in the 21st century. Patients with type 2 diabetes and individuals with prediabetes are at risk of developing macrovascular and microvascular complications. Long-term management strategies are therefore required that ar...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2007
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040135/ |